We have read with great interest Uchida and colleagues’ paper in your journal (2009;
29: 571–576), which reported that a high dosage of risperidone had a negative impact
on cognition in older patients with schizophrenia. This finding is consistent with that
of a previous study of a younger patient group showing that schizophrenia patients
under high antipsychotic dosage have poor cognitive function performance....